Zobrazeno 1 - 10
of 494
pro vyhledávání: '"Liang Mo"'
Publikováno v:
Non-coding RNA Research, Vol 9, Iss 3, Pp 667-677 (2024)
Lung cancer (LC) is considered to have the highest mortality rate around the world. Because there are no early diagnostic signs or efficient clinical alternatives, distal metastasis and increasing numbers of recurrences are a challenge in the clinica
Externí odkaz:
https://doaj.org/article/b2ce115b1369440c8cb89dc81117a759
Publikováno v:
Journal of Orthopaedic Translation, Vol 45, Iss , Pp 178-187 (2024)
Background: Glucocorticoid-induced osteonecrosis of the femoral head (GIONFH) is a common bone and joint disease. There is currently a lack of effective treatment for GIONFH, and the disease progression may lead to total hip arthroplasty (THA). The e
Externí odkaz:
https://doaj.org/article/6159720fad654f65a47bae6c73455de8
Publikováno v:
Biomolecules & Biomedicine (2024)
Advancements in artificial intelligence (AI) offer promising tools for improving diagnostic accuracy and patient outcomes in cardiovascular medicine. This study explores the potential of AI-assisted measurements in enhancing the prediction of major a
Externí odkaz:
https://doaj.org/article/10e4cf9bcce740a689f1dc2780abb286
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 18, Iss 1, Pp 1-12 (2023)
Abstract Background Non-vascularized bone grafting (NVBG) has demonstrated to treat osteonecrosis of the femoral head (ONFH). There are a number of articles updating the use of NVBG to treat the ONFH, but the percentage of patients subsequently under
Externí odkaz:
https://doaj.org/article/772df1c3471e4e17972b85b7d506b5c4
Autor:
Yuhao Liu, Liang Mo, Hongduo Lu, Yangwenxiang Wei, Jiahao Zhang, Samuel Bennett, Jiake Xu, Chi Zhou, Bin Fang, Zhenqiu Chen
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Objective: Dragon’s Blood resin (DBR) is a traditional medicinal substance renowned for its diverse pharmacological effects, which consists of potent anti-inflammatory, antioxidant and angiogenic properties. This study aimed to elucidate its therap
Externí odkaz:
https://doaj.org/article/587b68d37419470292575ae9cf779739
Autor:
Jiahao Zhang, Liang Mo, Haoran Huang, Jiake Xu, Yinuo Fan, Weifeng Li, Haibin Wang, Chi Zhou, Hanjun Fang, Wei He, Zhenqiu Chen, Yuhao Liu
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Excessive absorption of osteoclasts will break the balance between osteoclasts and osteoblasts, leading to bone loss, decreased bone density, and increased bone fragility. We have shown that Loureirin B (LrB) can inhibit osteoclasts. In this
Externí odkaz:
https://doaj.org/article/c03b8b6e2ad64694b27bcac9882f98c0
Autor:
Liang Mo, Chao Ma, Zhangzheng Wang, Jianxiong Li, Wei He, Wei Niu, Zhengqiu Chen, Chi Zhou, Yuhao Liu
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
BackgroundOsteoporosis and atherosclerosis are common in the elderly population, conferring a heavy worldwide burden. Evidence links osteoporosis and atherosclerosis but the exact underlying common mechanism of its occurrence is unclear. The purpose
Externí odkaz:
https://doaj.org/article/886f1cde808e491db9ac2584148c4f0c
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 16, Iss 1, Pp 1-11 (2021)
Abstract Background Postoperative delirium is a frequent event after cardiac surgery. This meta-analysis aimed to identify relevant risk factors. Method In this meta-analysis, all original researches regarding patients undergoing mixed types of cardi
Externí odkaz:
https://doaj.org/article/c78f9cadf40e42ee8803a637a725e1fa
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
ObjectiveTo identify risk factors of failure after Non-Vascularized Bone Grafting (NVBG) in osteonecrosis patients, establish and validate a nomogram predictive model of hip survival after NVBG.MethodsData on ONFH patients undergoing NVBG at our inst
Externí odkaz:
https://doaj.org/article/576084965ced418ba877daf02b525fd5
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Background The average 5-year survival rate of lung adenocarcinoma patients is only 15% to 17%, which is primarily due to late-stage diagnosis and a lack of specific prognostic evaluations that can recommend effective therapies. Additionally, there i
Externí odkaz:
https://doaj.org/article/1df46c5c4993440386eaf695903f671b